This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and hold the button
If you believe this is an error, please contact our support team.
192.64.82.12 : 3f98ec39-710f-422c-9457-4aa2c1df
Credit: Unsplash/CC0 Public Domain A pioneering study, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS),
Associations of disease risk with change in body mass index (BMI) or glycated haemoglobin (HbA1c). Credit: Diabetes, Obesity and Metabolism (2024). DOI:10.1111/dom.15896 A Cleveland Clinic research team has published the
When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies cover the medications in their health insurance plans, a
